Fundamental Analysis
15 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -11.7% | -14.4% | 0 / 3 | +4.0% | -4.62 pp | -6.39 pp | +2.4% | 0.26 | 71.89 | 79,4 | +4,0% | 28,6 | −11,7% | 71.89 | 43.14 | +66,6% |
| Pts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 17.900 (close price on 2026-08-12)EPS (TTM): 249,0
Financial charts
1.Revenue & growth
VND bn79,4Q2/26
1.Revenue & growth
VND bn79,4Q2/26
2.Profit & growth
VND bn28,6Q2/26
3.Profit mix (Penman)
VND bn14,7Q2/26
4.Margins & cost structure
%27.2%Q2/26
5.Returns & cash cycle
% · days3.1%Q2/26
6.Earnings quality & cash
VND bn13,5Q2/26
7.Asset structure
VND bn816Q2/26
8.Funding & debt health
VND bn · times816Q2/26
9.Revenue backlog
VND bn1,75Q2/26
10.Valuation
times · %72,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %490Q2/26
Adjusted EPS growth, latest quarter
-11.7%
Average adjusted EPS growth, 3 quarters
-11.7%
averaged over 1 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26